Digicann Ventures Inc. (AGFAF)

0.0111 0.0000 (0.00%) As of 09:30AM EDT. Market open.

Digicann Ventures Inc.

789 West Pender Street
Suite 810
Vancouver, BC V6C 1H2
Canada
800-783-6056
https://www.digicann.io

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Nicholas J. Kuzyk M.B.A.	CEO & Director	205.09k	N/A	1980
Ms. Fiona Fitzmaurice ACCA, B.A., BA, C.P.A., CGA	CFO & Director	103.5k	N/A	1981
Mr. Peter Karroll	Director of Branding & Marketing	N/A	N/A	N/A
Dr. Zbigniew Adam Szybinski M.Sc.	Vice President of Exploration	87.83k	N/A	N/A
Ms. Katrin Eckmans	MD & CEO of Farmako GmbH	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Digicann Ventures Inc., together with its subsidiaries, operates in the cannabis industry. The company engages in the cultivation, manufacturing, and marketing of cannabis and related products. Its flagship property is the Propagation Services Canada located in Delta, Canada. It also distributes medical cannabis in Europe. The company was formerly known as Agra Ventures Ltd. and changed its name to Digicann Ventures Inc. in August 2023. Digicann Ventures Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.

Corporate Governance

Digicann Ventures Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.